Back

VICTORION-Mono China: efficacy and safety of inclisiran as monotherapy in Chinese adults with low or moderate ASCVD risk and elevated LDL-C

29 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Dyslipidaemias: current strategies and innovations Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Xin Liu

(Switzerland)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Z. Zhang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Doctor E. Bolsteina (Riga, LV)
Abstract Slides
Presentation thumbnail
Ms H. Shen (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Professor S. Hong (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Dyslipidaemias: current strategies and innovations

The Event

Event poster

ESC Congress 2025

29 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of inclisiran monotherapy in patients with hypercholesterolemia without background lipid-lowering therapy: a systematic review and meta-analysis
thumbnail
Congress Presentation
Efficacy of inclisiran versus placebo in atherosclerotic cardiovascular disease: A systematic review and meta-analysis
thumbnail
Congress Presentation
Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources